UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy

European journal of cancer (1990), 2018-05, Vol.94, p.179-186

2018

Link zum Volltext

Verfügbarkeit prüfen

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Neuro-oncology (Charlottesville, Va.), 2017-08, Vol.19 (8), p.1047-1057

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients

International journal of cancer, 2020-06, Vol.146 (11), p.3087-3097

2020

Link zum Volltext

Verfügbarkeit prüfen

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies

International journal of molecular sciences, 2018-07, Vol.19 (7), p.2087

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

Cancers, 2021-11, Vol.13 (22), p.5749

2021

Link zum Volltext

Verfügbarkeit prüfen

BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents

Medicina (Kaunas, Lithuania), 2022-12, Vol.58 (12), p.1818

2022

Link zum Volltext

Verfügbarkeit prüfen

Population bias in somatic measurement of microsatellite instability status

Cancer medicine (Malden, MA), 2020-09, Vol.9 (17), p.6452-6460

2020

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions

Cancers, 2022-03, Vol.14 (6), p.1505

2022

Link zum Volltext

Verfügbarkeit prüfen

The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer

PLoS genetics, 2016-05, Vol.12 (5), p.e1006039-e1006039

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1722: Spectrum of solid malignancies associated with mutations in CYLD gene

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1722-1722

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4605: DICER1 mutations are associated with diverse and frequently histologically mixed-type malignancies in young and adult patients

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4605-4605

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4740: Molecular profiling of adenoid cystic carcinomas

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4740-4740

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract A035: Therapeutic targets in androgen deprivation therapy-resistant prostatic carcinoma

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.A035-A035

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel EGFL7–FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease

Histopathology, 2021-11, Vol.79 (5), p.888-891

2021

Link zum Volltext

Verfügbarkeit prüfen

Fetal Type Morphologies Suggest the Presence of DICER1 Hotspot Mutations in Non-small Cell Lung Cancer

The American journal of surgical pathology, 2024-02, Vol.48 (2), p.221

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3639: Fusion-associated neoantigen burden and predicted immunogenicity of CDK12 biallelic loss-of-function tumors vary substantially across cancer types

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3639-3639

2020

Link zum Volltext

Verfügbarkeit prüfen

Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature

Pathology, 2017-06, Vol.49 (4), p.447-450

2017

Link zum Volltext

Verfügbarkeit prüfen

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC): Track: Biology and Pathogenesis

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S221-S221

2016

Link zum Volltext

Verfügbarkeit prüfen

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.S221

2016

Link zum Volltext

Verfügbarkeit prüfen

IBRCA1/2/I Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase Inhibitors or Platinum Agents

Medicina (Kaunas, Lithuania), 2022-12, Vol.58 (12)

2022

Link zum Volltext

Verfügbarkeit prüfen

PCR with Random Primers to Obtain Sequence from Yeast Artificial Chromosome Insert Ends or Plasmids

BioTechniques, 1996-03, Vol.20 (3), p.486-491

Swensen, Jeff

1996

Link zum Volltext

Verfügbarkeit prüfen

Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study

Head & neck pathology (Totowa, N.J.), 2019-06, Vol.13 (2), p.162-168

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series

Journal of human genetics, 2002-01, Vol.47 (12), p.641-648

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)
Berichte
(1)

Sprache

Englisch
(49)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(6)
American Journal Of Respiratory And Critical Care Medicine
(2)
Cancers
(2)
European Journal Of Cancer
(2)
Genomics
(2)
Journal Of Thoracic Oncology
(2)
Lung Cancer
(2)
Mayo Clinic Proceedings
(2)
Medicina
(2)
Radiology
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer

Towards Molecular Profiling in Multiple Myeloma: A Literature Review and Early Indications of Its Efficacy for Informing Treatment Strategies

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents

Population bias in somatic measurement of microsatellite instability status

Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions

The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer

Abstract 1722: Spectrum of solid malignancies associated with mutations in CYLD gene

Abstract 4605: DICER1 mutations are associated with diverse and frequently histologically mixed-type malignancies in young and adult patients

Abstract 4740: Molecular profiling of adenoid cystic carcinomas

Abstract A035: Therapeutic targets in androgen deprivation therapy-resistant prostatic carcinoma

Novel EGFL7–FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease

Fetal Type Morphologies Suggest the Presence of DICER1 Hotspot Mutations in Non-small Cell Lung Cancer

Abstract 3639: Fusion-associated neoantigen burden and predicted immunogenicity of CDK12 biallelic loss-of-function tumors vary substantially across cancer types

Primary renal sclerosing epithelioid fibrosarcoma: a case report and review of the literature

Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC): Track: Biology and Pathogenesis

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

IBRCA1/2/I Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase Inhibitors or Platinum Agents

PCR with Random Primers to Obtain Sequence from Yeast Artificial Chromosome Insert Ends or Plasmids

Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing Study

Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series

Suchergebnisse filtern